Across two new papers published Wednesday (July 23) in the journal Nature, scientists sequenced the DNA of 1,084 people ...

Researchers led by UC Davis Health scientist Sanchita Bhatnagar have developed a promising gene therapy that could treat Rett ...

Complex regions of the human genome remained uncharted, even after researchers sequenced the genome in its entirety. That is, ...

Scientists have found a surprising connection between vitamin D and a single gene called SDR42E1.

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity - ...

Cutting-edge gene editing technology could eradicate Down syndrome, according to Japanese scientists. Down syndrome, which causes a range of developmental differences and affects 1 in 700 newborns ...

Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.

Boston-based Verve is a rare example of a gene-editing company targeting a disease that affects a large population, offering better commercial prospects.

Shares of Verve Therapeutics skyrocketed 75% Tuesday morning after Eli Lilly announced that it would acquire the gene-editing startup for about $1.3 billion.

A patient’s genes may affect which GLP-1 obesity drugs work best, researchers say Other factors that influence the impact include how much people need to eat to full feel.

A mom from Colorado was left stunned by her two children who have defied genetics. Nadiyah Luwan Smith (@nadiismiith) posted a clip on TikTok of her two children—both born with blue eyes and ...